Marta Gustavo Nader, Poortmans Philip M, Buchholz Thomas A, Hijal Tarek
Hospital Sírio-Libanês and Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil.
Radboud University Medical Center, Nijmegen, The Netherlands.
Breast J. 2017 Jan;23(1):26-33. doi: 10.1111/tbj.12683. Epub 2016 Sep 9.
Skin sparing mastectomy, a surgical procedure sparing a large portion of the overlying skin of the breast, and nipple-sparing mastectomy, sparing the whole nipple-areolar complex, are increasingly used, although their oncologic efficacy remains unclear. The aim of this study was to assess the radiation oncologists' opinions regarding the indications of radiation therapy (RT) after skin-sparing mastectomy and nipple-sparing mastectomy. Radiation oncology members of four national and international societies were invited to complete a questionnaire comprising of 22 questions to assess their opinions regarding RT indications in the context of skin-sparing and nipple-sparing mastectomy. A total of 298 radiation oncologists answered the questionnaire. 90.9% of respondents affirmed that breast cancer is one of their specializations. The majority declared that post-mastectomy RT is indicated for early-stage (stages I and II) breast cancer patients who present with risk factors for recurrence after skin-sparing or nipple-sparing mastectomy (87.2% and 80.2%, respectively). All suggested risk factors (tumor size, lymph node involvement, extracapsular extension, lymphovascular space invasion, positive surgical margins, triple negative tumor, multicentric tumor, and age) were considered as major elements (important or very important). There is no consensus regarding the necessity of evaluating residual breast tissue or the definition of residual breast tissue after mastectomy. All classic factors were considered as major elements, potentially influencing the decision to advice or not postoperative RT. Many uncertainties remain about the indications for RT after skin-sparing mastectomy or nipple-sparing mastectomy.
保留皮肤的乳房切除术是一种保留大部分乳房皮肤的外科手术,而保留乳头乳晕复合体的乳房切除术则保留整个乳头乳晕复合体,这两种手术的应用越来越广泛,但其肿瘤学疗效仍不明确。本研究的目的是评估放射肿瘤学家对保留皮肤乳房切除术和保留乳头乳晕复合体乳房切除术后放射治疗(RT)适应证的看法。邀请了四个国家和国际学会的放射肿瘤学成员填写一份包含22个问题的问卷,以评估他们对保留皮肤和保留乳头乳晕复合体乳房切除术中RT适应证的看法。共有298名放射肿瘤学家回答了问卷。90.9%的受访者确认乳腺癌是他们的专业领域之一。大多数人宣称,乳房切除术后放疗适用于保留皮肤或保留乳头乳晕复合体乳房切除术后存在复发危险因素的早期(I期和II期)乳腺癌患者(分别为87.2%和80.2%)。所有建议的危险因素(肿瘤大小、淋巴结受累情况、包膜外扩展、淋巴管间隙侵犯、手术切缘阳性、三阴性肿瘤、多中心肿瘤和年龄)都被视为主要因素(重要或非常重要)。对于乳房切除术后评估残余乳腺组织的必要性或残余乳腺组织的定义,尚无共识。所有经典因素都被视为主要因素,可能影响是否建议术后放疗的决定。关于保留皮肤乳房切除术或保留乳头乳晕复合体乳房切除术后放疗的适应证,仍存在许多不确定性。